Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6/2 mouse model of Huntington's disease.

Brain research bulletin - 10 Feb 2012

Anzilotti Serenella, Giampà Carmela, Laurenti Daunia, Perrone Lorena, Bernardi Giorgio, Melone Mariarosa A B, Fusco Francesca R

Abstract excerpt

The receptor for advanced glycation end (RAGE) products is a multi-ligand receptor that belongs to the immunoglobulin superfamily of cell surface receptors, whose ligands are known to be upregulated in neuropathological conditions. RAGE upregulation has been described in neurodegenerative diseases, such as Alzheimer's disease, Creutzfeldt-Jakob's disease and Huntington's disease (HD). To analyze in detail the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calbindins
Share to Cholinesterases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Corpus Striatum

Share to Parvalbumins

Share to Phosphopyruvate Hydratase

Share to Receptor for Advanced Glycation End Products

Share to S100 Calcium Binding Protein G

Share to Somatostatin

Source

Identifiers

PMID: 21272617
DOI: 10.1016/j.brainresbull.2011.01.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6/2 mouse model of Huntington's disease.PMID 21272617Read ↗

Localization of neuroglobin in the brain of R6/2 mouse model of Huntington's disease.Semantic proximity Read ↗

Retinal affectation in Huntington’s disease mouse models concurs with a local innate immune responseSemantic proximity Read ↗

Current Evidence on the Involvement of RAGE-Diaph1 Signaling in the Pathology and Treatment of Neurodegenerative Diseases – an OverviewSemantic proximity Read ↗

Early retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington's disease.Semantic proximity Read ↗

R6/2 neurons with intranuclear inclusions survive for prolonged periods in the brains of chimeric mice.Semantic proximity Read ↗

Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic miceSemantic proximity Read ↗

Impaired adult olfactory bulb neurogenesis in the R6/2 mouse model of Huntington's disease.Semantic proximity Read ↗

Depletion of Complexin II does not affect disease progression in a mouse model of Huntington's disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD.Semantic proximity Read ↗

R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures.Semantic proximity Read ↗

Use of magnetic resonance imaging for anatomical phenotyping of the R6/2 mouse model of Huntington's disease.Semantic proximity Read ↗

Transglutaminase 6 Is Colocalized and Interacts with Mutant Huntingtin in Huntington Disease Rodent Animal Models.Semantic proximity Read ↗

Distinct histological alterations of cortical interneuron types in mouse models of Huntington’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.